Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab.

ABSTRACT:

SUBMITTER: Na Z 

PROVIDER: S-EPMC5223238 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature